VIROGATES A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.5 DKK | -11.92% |
|
+8.33% | +7.97% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 181.9 | 104 | 254.5 | 456.1 | 134.3 | 38.81 |
| Enterprise Value (EV) 1 | 121.8 | 62.58 | 221 | 441.3 | 124.4 | 28.09 |
| P/E ratio | -9.31 x | -5.54 x | -13.4 x | -25.7 x | -13.5 x | -1.72 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 54.9 x | 29 x | 47.5 x | 59.6 x | 8.83 x | 5.56 x |
| EV / Revenue | 36.7 x | 17.5 x | 41.3 x | 57.6 x | 8.18 x | 4.02 x |
| EV / EBITDA | -6.78 x | -3.19 x | -11.3 x | -23.8 x | -11.7 x | -2.24 x |
| EV / FCF | -10.9 x | -5.07 x | -23.3 x | -28.2 x | -10.8 x | -3.39 x |
| FCF Yield | -9.21% | -19.7% | -4.29% | -3.54% | -9.23% | -29.5% |
| Price to Book | 2.98 x | 2.46 x | 8.13 x | 27.8 x | 8.34 x | 2.28 x |
| Nbr of stocks (in thousands) | 3,032 | 3,032 | 3,123 | 3,167 | 3,348 | 6,448 |
| Reference price 2 | 60.00 | 34.30 | 81.50 | 144.0 | 40.10 | 6.020 |
| Announcement Date | 3/27/19 | 2/29/20 | 3/1/21 | 3/23/22 | 3/23/23 | 3/21/24 |
1DKK in Million2DKK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3.316 | 3.582 | 5.354 | 7.656 | 15.2 | 6.987 |
| EBITDA 1 | -17.98 | -19.61 | -19.5 | -18.57 | -10.67 | -12.52 |
| EBIT 1 | -18.1 | -19.72 | -19.73 | -18.79 | -10.84 | -12.56 |
| Operating Margin | -545.9% | -550.61% | -368.49% | -245.42% | -71.36% | -179.82% |
| Earnings before Tax (EBT) 1 | -18.92 | -20.01 | -19.98 | -18.96 | -10.88 | -13.09 |
| Net income 1 | -16.99 | -18.8 | -18.74 | -17.66 | -9.646 | -12.1 |
| Net margin | -512.24% | -524.76% | -349.94% | -230.71% | -63.47% | -173.12% |
| EPS 2 | -6.441 | -6.195 | -6.079 | -5.602 | -2.963 | -3.495 |
| Free Cash Flow 1 | -11.22 | -12.34 | -9.487 | -15.64 | -11.48 | -8.291 |
| FCF margin | -338.42% | -344.36% | -177.19% | -204.26% | -75.53% | -118.67% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/27/19 | 2/29/20 | 3/1/21 | 3/23/22 | 3/23/23 | 3/21/24 |
1DKK in Million2DKK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 60.1 | 41.4 | 33.5 | 14.9 | 9.88 | 10.7 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -11.2 | -12.3 | -9.49 | -15.6 | -11.5 | -8.29 |
| ROE (net income / shareholders' equity) | -53.1% | -36.4% | -51% | -74% | -59.3% | -73.1% |
| ROA (Net income/ Total Assets) | -33.1% | -22.7% | -29.6% | -40.2% | -35.9% | -37.3% |
| Assets 1 | 51.35 | 82.79 | 63.36 | 43.98 | 26.87 | 32.42 |
| Book Value Per Share 2 | 20.10 | 13.90 | 10.00 | 5.190 | 4.810 | 2.640 |
| Cash Flow per Share 2 | 19.80 | 13.70 | 10.70 | 4.690 | 2.950 | 2.490 |
| Capex | - | 0.55 | 0.11 | - | - | - |
| Capex / Sales | - | 15.24% | 2.13% | - | - | - |
| Announcement Date | 3/27/19 | 2/29/20 | 3/1/21 | 3/23/22 | 3/23/23 | 3/21/24 |
1DKK in Million2DKK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +7.97% | 6M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 383M |
- Stock Market
- Equities
- VIRO Stock
- Financials ViroGates A/S
